Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

BACKGROUND: Recognizing resistance or susceptibility to the current standard cisplatin and paclitaxel treatment could improve therapeutic outcomes of metastatic or recurrent cervical cancer. METHODS: Forty-five tissue samples from patients participating in a phase II trial of cisplatin and ifosfamid...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Karageorgopoulou, Sofia, Kostakis, Ioannis D., Gazouli, Maria, Markaki, Sonia, Papadimitriou, Marios, Bournakis, Evangelos, Dimopoulos, Meletios-Athanassios, Papadimitriou, Christos A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490227/
https://ncbi.nlm.nih.gov/pubmed/28659181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3435-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia